97 results on '"Tammela, Teuvo"'
Search Results
2. Abstract 4720: Chromatin conformation alterations in prostate cancer progression and formation of castration resistance
3. Abstract 5644: Spatially resolved transcriptomics points to distinct malignant cell populations within primary and castration resistant prostate cancer
4. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
5. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
6. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
7. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
8. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
9. Supplementary Table 5 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
10. Supplementary notes from Genome-Wide Association Study of Prostate Cancer–Specific Survival
11. Supplementary Table 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
12. Appendix Table 1. from The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC)
13. Data from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
14. Supplementary Table 2 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
15. Data from Genome-Wide Association Study of Prostate Cancer–Specific Survival
16. Supplementary Table 3 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
17. Supplementary data_310718 from Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer
18. Supplementary Table 4 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
19. Supplementary Figure 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
20. Data from Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
21. Supplementary Data from Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
22. Data from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
23. Supplementary Figure 3 from MicroRNA Expression Profiling in Prostate Cancer
24. Supplementary Figure 2 from MicroRNA Expression Profiling in Prostate Cancer
25. Supplementary Table 1 from MicroRNA Expression Profiling in Prostate Cancer
26. Supplementary Table S4 from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
27. Supplementary Figure 4 from MicroRNA Expression Profiling in Prostate Cancer
28. Supplementary Table 2 from MicroRNA Expression Profiling in Prostate Cancer
29. Supplementary Methods and References from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
30. Supplementary Figures S1-S9 from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
31. Supplementary Figure Legends 1-4 from MicroRNA Expression Profiling in Prostate Cancer
32. Supplementary Figure 1 from MicroRNA Expression Profiling in Prostate Cancer
33. Supplementary Figure Legends from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
34. Abstract 121: Differential resistance to hypoxia is linked to increased lipid accumulation in treatment resistant prostate cancer cells
35. Abstract 401: Single-cell transcriptome and chromatin sequencing uncover gene expression and gene regulatory patterns associated with enzalutamide resistance
36. Antidiabetic Drugs and Prostate Cancer Prognosis in a Finnish Population-Based Cohort
37. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
38. Abstract 3513: Genome-wide scan for novel prostate cancer susceptibility loci with clinical consequence utilizing increased genetic drift of the Finnish population
39. Abstract 5913: Genetic landscape changes in metastatic prostate cancer after sequential steps of androgen targeted therapy
40. Abstract LB-149: Serum thymidine kinase 1 levels predict prostate cancer-specific survival
41. Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer
42. The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC)
43. Abstract CT133: Atorvastatin and prostate cancer - a phase 2 clinical trial
44. Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening
45. Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
46. Abstract 4681: Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish arm of the European randomised study of screening for prostate cancer (ERSPC)
47. Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
48. Abstract 3648: Unraveling phenotype heterogeneity in prostate cancer susceptibility in Finland utilizing covariate-based analysis.
49. Abstract 5217: Integrative sequencing reveals novel alterations in untreated and castration resistant prostate cancer.
50. HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.